Leave a Reply

5 Comments on "Kerrisdale Capital’s Sahm Adrangi Remains Thumbs Down on Northern Dynasty Minerals"

Notify of
trackback

[…] Sahm Adrangi is concerned that this company’s claims have actually been falsified because of the pressure against them for creating a product that is successful. Not only is their data largely incomplete and devoid of test results, but Proteostasis stands to lose the majority of their company value should this drug not work out. With all of the problems looking into this biotech company, Sahm is warning people of their claims and investors to stay clear. Since Kerrisdale’s report released, Proteostasis’s company stock value has decreased by 16 percent, amounting to tens of millions of dollars. […]

trackback

[…] ICO craze. They additionally believe this will not offset the unsustainable capital structure and poor fundamentals of Kodak. Kerrisdale will be hosting a conference call to discuss the report they have published […]

trackback

[…] is whether the company has invested heavily in the coin to the point where they could have wasted a lot of money that could have been invested in other […]

trackback

[…] makes them tough when combined with company’s like Eastman Kodak, being a former giant in the photography and printing industry. Despite the recent increase in share prices, Kodak has not changed any of the business strategies […]

wpDiscuz